A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-c...

Por LeCaer, H, Barlesi, F, Corre, R, Jullian, H, Bota, S, Falchero, L, Vergnenegre, A, Dujon, C, Delhoume, J Y, Chouaid, C
Publicado em 2011